FKnol.com

Financial Knowledge & Information Portal

Major Pharmaceuticals Sector Stock List

Updated Apr 18, 2019
The Major Pharmaceuticals subsector (industrial classification) falls under the broader Health Care sector. The following list presents stocks of the companies which belong to the Major Pharmaceuticals class. Fknol.com has a total of 396 stocks in its records for the companies belonging to Major Pharmaceuticals category.

Stocks of Major Pharmaceuticals Sector

Stock List

▶ Abbott Labs (ABT): The NYSE-listed North Chicago, Illinois-based Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile  and Dividend History.

▶ AbbVie (ABBV): The NYSE-listed North Chicago, Illinois-based AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile  and Dividend History.

▶ Abeona Therapeutics (ABEO): The NASDAQ-listed Texas, TX-based Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile  and Dividend History.

▶ Abeona Therapeutics (ABEOW): The NASDAQ-listed Texas, TX-based ....See Detailed Company Profile  and Dividend History.

▶ AC Immune SA (ACIU): The NASDAQ-listed Switzerland-based AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile  and Dividend History.

▶ ACADIA Pharma (ACAD): The NASDAQ-listed California, CA-based ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile  and Dividend History.

▶ Acasti Pharma (ACST): The NASDAQ-listed Canada-based Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile  and Dividend History.

▶ AcelRx Pharma (ACRX): The NASDAQ-listed California, CA-based AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile  and Dividend History.

▶ Achaogen (AKAO): The NASDAQ-listed California, CA-based Achaogen, Inc., incorporated on November 26, 2002, is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative ....See Detailed Company Profile  and Dividend History.

▶ Achillion Pharma (ACHN): The NASDAQ-listed Connecticut, CT-based Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile  and Dividend History.

▶ Aclaris Therapeutics (ACRS): The NASDAQ-listed Pennsylvania, PA-based Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile  and Dividend History.

▶ Actinium Pharma (ATNM): The AMEX-listed New York, NY-based Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile  and Dividend History.

▶ Acura Pharma (ACUR): The NASDAQ-listed Palatine, IL-based Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile  and Dividend History.

▶ Adamas Pharma (ADMS): The NASDAQ-listed California, CA-based Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile  and Dividend History.

▶ Adamis Pharma (ADMP): The NASDAQ-listed California, CA-based Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile  and Dividend History.

▶ Aduro Biotech (ADRO): The NASDAQ-listed California, CA-based Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile  and Dividend History.

▶ Advanced Accelerator Applications (AAAP): The NASDAQ-listed France-based Advanced Accelerator Applications S.A., incorporated on March 1, 2002, is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace ....See Detailed Company Profile  and Dividend History.

▶ Advaxis (ADXS): The NASDAQ-listed New Jersey, NJ-based Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile  and Dividend History.

▶ Advaxis (ADXSW): The NASDAQ-listed New Jersey, NJ-based ....See Detailed Company Profile  and Dividend History.

▶ Aeglea BioTherapeutics (AGLE): The NASDAQ-listed Texas, TX-based Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile  and Dividend History.

▶ AEterna Zentaris (AEZS): The NASDAQ-listed Canada-based Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile  and Dividend History.

▶ Affimed (AFMD): The NASDAQ-listed Germany-based Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile  and Dividend History.

▶ Agile Therapeutics (AGRX): The NASDAQ-listed New Jersey, NJ-based Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile  and Dividend History.

▶ Agios Pharma (AGIO): The NASDAQ-listed Massachusetts, MA-based Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile  and Dividend History.

▶ Aimmune Therapeutics (AIMT): The NASDAQ-listed California, CA-based Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ....See Detailed Company Profile  and Dividend History.

▶ Akari Therapeutics (AKTX): The NASDAQ-listed New York, NY-based Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, incorporated on October 7, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of treatments for a ....See Detailed Company Profile  and Dividend History.

▶ Akebia Therapeutics (AKBA): The NASDAQ-listed Massachusetts, MA-based Akebia Therapeutics, Inc., incorporated on February 27, 2007, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Companys ....See Detailed Company Profile  and Dividend History.

▶ Akorn (AKRX): The NASDAQ-listed Illinois, IL-based Akorn Inc. (Akorn), incorporated on January 20, 1971, together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well ....See Detailed Company Profile  and Dividend History.

▶ Albireo Pharma (ALBO): The NASDAQ-listed Connecticut, CT-based Albireo Pharma, Inc., formerly Biodel Inc., incorporated on December 8, 2003, is a specialty biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to ....See Detailed Company Profile  and Dividend History.

▶ Alcobra (ADHD): The NASDAQ-listed Israel-based Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid ....See Detailed Company Profile  and Dividend History.

▶ Alder BioPharma (ALDR): The NASDAQ-listed Washington, WA-based Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alders lead ....See Detailed Company Profile  and Dividend History.

▶ Aldeyra Therapeutics (ALDX): The NASDAQ-listed Massachusetts, MA-based Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., incorporated on August 13, 2004, is a biotechnology company. The Companys principal activities include raising capital and research and development activities. The Companys ....See Detailed Company Profile  and Dividend History.

▶ Alexion Pharma (ALXN): The NASDAQ-listed Cheshire, Connecticut-based Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companys products include Soliris (eculizumab), ....See Detailed Company Profile  and Dividend History.

▶ Alimera Sciences (ALIM): The NASDAQ-listed Georgia, GA-based Alimera Sciences, Inc. (Alimera), incorporated on June 4, 2003, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates ....See Detailed Company Profile  and Dividend History.

▶ Alkermes (ALKS): The NASDAQ-listed Ireland-based Alkermes plc, incorporated on May 4, 2011, is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs ....See Detailed Company Profile  and Dividend History.

▶ Allergan (AGN): The NYSE-listed Dublin, Ireland-based Allergan plc, incorporated on May 16, 2013, is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, ....See Detailed Company Profile  and Dividend History.

▶ Alnylam Pharma (ALNY): The NASDAQ-listed Massachusetts, MA-based Alnylam Pharmaceuticals, Inc., incorporated on May 8, 2003, is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The ....See Detailed Company Profile  and Dividend History.

▶ AMAG Pharma (AMAG): The NASDAQ-listed Massachusetts, MA-based AMAG Pharmaceuticals, Inc., incorporated on November 9, 1981, is a pharmaceutical company. The Companys segment is the manufacture, development and commercialization of products and services for use in treating various ....See Detailed Company Profile  and Dividend History.

▶ Amarin (AMRN): The NASDAQ-listed Ireland-based Amarin Corporation plc, incorporated on March 1, 1989, is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company ....See Detailed Company Profile  and Dividend History.

▶ Amicus Therapeutics (FOLD): The NASDAQ-listed New Jersey, NJ-based Amicus Therapeutics, Inc., incorporated on February 4, 2002, is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living ....See Detailed Company Profile  and Dividend History.

▶ Amphastar Pharma (AMPH): The NASDAQ-listed California, CA-based Amphastar Pharmaceuticals, Inc., incorporated on May 19, 2004, is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. ....See Detailed Company Profile  and Dividend History.

▶ Ampio Pharma (AMPE): The AMEX-listed Colorado, CO-based Ampio Pharmaceuticals, Inc., incorporated on March 24, 2010, is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there ....See Detailed Company Profile  and Dividend History.

▶ ANI Pharma (ANIP): The NASDAQ-listed Illinois, IL-based ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company ....See Detailed Company Profile  and Dividend History.

▶ Anthera Pharma (ANTH): The NASDAQ-listed California, CA-based Anthera Pharmaceuticals, Inc. (Anthera), incorporated on October 9, 2004, is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies ....See Detailed Company Profile  and Dividend History.

▶ Aoxing Pharmaceutical (AXN): The AMEX-listed New Jersey, NJ-based Aoxing Pharmaceutical Company, Inc., incorporated on January 24, 1996, is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment ....See Detailed Company Profile  and Dividend History.

▶ Apricus Biosciences (APRI): The NASDAQ-listed California, CA-based Apricus Biosciences, Inc., incorporated on October 20, 1987, is a pharmaceutical company, which develops pharmaceutical products. The Company primarily focuses on the development and commercialization of products and product candidates ....See Detailed Company Profile  and Dividend History.

▶ Aptevo Therapeutics (APVO): The NASDAQ-listed Washington, WA-based Aptevo Therapeutics Inc., incorporated on February 22, 2016, is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization ....See Detailed Company Profile  and Dividend History.

▶ Aquinox Pharma (AQXP): The NASDAQ-listed Canada-based Aquinox Pharmaceuticals, Inc., incorporated on May 25, 2007, is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Companys primary focus is ....See Detailed Company Profile  and Dividend History.

▶ Aralez Pharma (ARLZ): The NASDAQ-listed North Carolina, NC-based Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Companys products include Fibricor, Cambia, ....See Detailed Company Profile  and Dividend History.

▶ Aratana Therapeutics (PETX): The NASDAQ-listed Kansas, KS-based Aratana Therapeutics, Inc., incorporated on December 1, 2010, is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Companys portfolio includes therapeutic ....See Detailed Company Profile  and Dividend History.

▶ Arbutus Biopharma (ABUS): The NASDAQ-listed Canada-based Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, is a therapeutic solutions company. The Company is engaged in discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B ....See Detailed Company Profile  and Dividend History.

▶ Ardelyx (ARDX): The NASDAQ-listed California, CA-based Ardelyx, Inc., incorporated on October 18, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. The Company operates through the research, development ....See Detailed Company Profile  and Dividend History.

▶ Arena Pharma (ARNA): The NASDAQ-listed California, CA-based Arena Pharmaceuticals, Inc., incorporated on April 14, 1997, is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has ....See Detailed Company Profile  and Dividend History.

▶ Argos Therapeutics (ARGS): The NASDAQ-listed North Carolina, NC-based Argos Therapeutics, Inc. (Argos), incorporated on May 8, 1997, is an immuno-oncology company. The Company is focused on the development and commercialization of individualized immunotherapies for the treatment of cancer ....See Detailed Company Profile  and Dividend History.

▶ ArQule (ARQL): The NASDAQ-listed Massachusetts, MA-based ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. It offers Derazantinib (ARQ 087), a multi-kinase inh....See Detailed Company Profile  and Dividend History.

▶ Array BioPharma (ARRY): The NASDAQ-listed Colorado, CO-based Array BioPharma Inc. (Array), incorporated on February 6, 1998, is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with ....See Detailed Company Profile  and Dividend History.

▶ Arrowhead Pharma (ARWR): The NASDAQ-listed California, CA-based Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic ....See Detailed Company Profile  and Dividend History.

▶ Ascendis Pharma AS (ASND): The NASDAQ-listed Denmark-based Ascendis Pharma A/S, incorporated on September 21, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several ....See Detailed Company Profile  and Dividend History.

▶ Assembly Biosciences (ASMB): The NASDAQ-listed Indiana, IN-based Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral sy....See Detailed Company Profile  and Dividend History.

▶ Astrazeneca (AZN): The NYSE-listed United Kingdom-based AstraZeneca PLC (AstraZeneca), incorporated on June 17, 1992, is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company ....See Detailed Company Profile  and Dividend History.

▶ Athersys (ATHX): The NASDAQ-listed Ohio, OH-based Athersys, Inc., incorporated on June 7, 2005, is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Companys MultiStem cell therapy, an allogeneic stem ....See Detailed Company Profile  and Dividend History.

▶ Aurinia Pharma (AUPH): The NASDAQ-listed Canada-based Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Companys primary business is the development of a therapeutic drug to treat ....See Detailed Company Profile  and Dividend History.

▶ Auris Medical Holding AG (EARS): The NASDAQ-listed Switzerland-based Auris Medical Holding AG, incorporated on April 15, 1998, is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. The ....See Detailed Company Profile  and Dividend History.

▶ Avadel Pharma (AVDL): The NASDAQ-listed France-based Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. Micropump is a microparticulate system that allows the ....See Detailed Company Profile  and Dividend History.

▶ AVEO Pharma (AVEO): The NASDAQ-listed Massachusetts, MA-based AVEO Pharmaceuticals, Inc. (AVEO), incorporated on October 19, 2001, is a biopharmaceutical company. The Companys platform delivers insights into cancer and related disease. The Companys product candidates include Tivozanib, Ficlatuzumab, ....See Detailed Company Profile  and Dividend History.

▶ Axovant Sciences (AXON): The NYSE-listed Bermuda-based Axovant Sciences Ltd., formerly Roivant Neurosciences Ltd., incorporated on October 31, 2014, is a clinical-stage biopharmaceutical company focused on acquiring, developing and commercializing therapeutics for the treatment of dementia. The ....See Detailed Company Profile  and Dividend History.

▶ Axsome Therapeutics (AXSM): The NASDAQ-listed New York, NY-based Axsome Therapeutics, Inc., incorporated on January 12, 2012, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including ....See Detailed Company Profile  and Dividend History.

▶ BeiGene (BGNE): The NASDAQ-listed Cayman Islands-based BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had ....See Detailed Company Profile  and Dividend History.

▶ Bellerophon Therapeutics (BLPH): The NASDAQ-listed New Jersey, NJ-based Bellerophon Therapeutics, Inc., incorporated on October 17, 2013, is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical ....See Detailed Company Profile  and Dividend History.

▶ Bellicum Pharma (BLCM): The NASDAQ-listed Texas, TX-based Bellicum Pharmaceuticals, Inc., incorporated on July 14, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological ....See Detailed Company Profile  and Dividend History.

▶ Benitec Biopharma (BNTC): The NASDAQ-listed Australia-based Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and ....See Detailed Company Profile  and Dividend History.

▶ Benitec Biopharma (BNTCW): The NASDAQ-listed Australia-based ....See Detailed Company Profile  and Dividend History.

▶ Bio-Path (BPTH): The NASDAQ-listed Texas, TX-based Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for ....See Detailed Company Profile  and Dividend History.

▶ Bioblast Pharma (ORPN): The NASDAQ-listed Israel-based Bio Blast Pharma Ltd. (BioBlast), incorporated on January 22, 2012, is a development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for ....See Detailed Company Profile  and Dividend History.

▶ BioDelivery Sciences Intl (BDSI): The NASDAQ-listed North Carolina, NC-based BioDelivery Sciences International, Inc., incorporated on April 18, 2002, is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications ....See Detailed Company Profile  and Dividend History.

▶ BioLineRx (BLRX): The NASDAQ-listed Israel-based BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates ....See Detailed Company Profile  and Dividend History.

▶ BioMarin Pharmaceutical (BMRN): The NASDAQ-listed California, CA-based BioMarin Pharmaceutical Inc., incorporated on October 25, 1996, is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the ....See Detailed Company Profile  and Dividend History.

▶ BioPharmX (BPMX): The AMEX-listed California, CA-based BioPharmX Corporation, incorporated on April 24, 2014, is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) ....See Detailed Company Profile  and Dividend History.

▶ BioSpecifics (BSTC): The NASDAQ-listed New York, NY-based BioSpecifics Technologies Corp. (BioSpecifics), incorporated on November 1, 1990, is a biopharmaceutical company. The Company is engaged in the development of an injectable collagenase clostridium histolyticum (CCH) for multiple indications. ....See Detailed Company Profile  and Dividend History.

▶ Biostar Pharma (BSPM): The NASDAQ-listed China-based Biostar Pharmaceuticals, Inc. (Biostar), incorporated on March 27, 2007, is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), ....See Detailed Company Profile  and Dividend History.

▶ Bioverativ (BIVV): The NASDAQ-listed Waltham, MA-based ....See Detailed Company Profile  and Dividend History.

▶ Blueprint Medicines (BPMC): The NASDAQ-listed Massachusetts, MA-based Blueprint Medicines Corporation, incorporated on October 14, 2008, is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. The Company focuses on ....See Detailed Company Profile  and Dividend History.

▶ Bristol-Myers Squibb (BMY): The NYSE-listed New York, NY-based Bristol-Myers Squibb Company, incorporated on August 11, 1933, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Companys pharmaceutical products include chemically synthesized ....See Detailed Company Profile  and Dividend History.

▶ Calithera Biosciences (CALA): The NASDAQ-listed California, CA-based Calithera Biosciences, Inc., incorporated on March 9, 2010, is a clinical-stage pharmaceutical company. The Company focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets ....See Detailed Company Profile  and Dividend History.

▶ Cambrex (CBM): The NYSE-listed New Jersey, NJ-based Cambrex Corporation (Cambrex), incorporated on October 11, 1983, is a life sciences company. The Company provides products and services for the development and commercialization of generic therapeutics. Cambrex operates through ....See Detailed Company Profile  and Dividend History.

▶ Can-Fite Biopharma (CANF): The AMEX-listed Israel-based Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company?ÇÖs drugs are CF101 for Psoriasis treatment, RA treatment, for ....See Detailed Company Profile  and Dividend History.

▶ Capricor Therapeutics (CAPR): The NASDAQ-listed California, CA-based Capricor Therapeutics, Inc., incorporated on January 26, 2007, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing ....See Detailed Company Profile  and Dividend History.

▶ Cara Therapeutics (CARA): The NASDAQ-listed Connecticut, CT-based Cara Therapeutics, Inc., incorporated on July 2, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by ....See Detailed Company Profile  and Dividend History.

▶ Cardiome Pharma (CRME): The NASDAQ-listed Canada-based Cardiome Pharma Corp. (Cardiome), incorporated on March 1, 2009, is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The ....See Detailed Company Profile  and Dividend History.

▶ Catabasis Pharma (CATB): The NASDAQ-listed Massachusetts, MA-based Catabasis Pharmaceuticals, Inc., incorporated on June 26, 2008, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized ....See Detailed Company Profile  and Dividend History.

▶ Catalent (CTLT): The NYSE-listed New Jersey, NJ-based Catalent, Inc., incorporated on March 14, 2007, is a provider of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. The Companys segments include Softgel ....See Detailed Company Profile  and Dividend History.

▶ Catalyst Biosciences (CBIO): The NASDAQ-listed North Carolina, NC-based CB 813dThe Companys product candidate, CB 813d, is a next-generation Factor VIIa that has completed Phase I clinical trial. The clinical trial has evaluated the safety and tolerability, pharmacokinetics, pharmacodynamics ....See Detailed Company Profile  and Dividend History.

▶ Catalyst Pharma (CPRX): The NASDAQ-listed Florida, FL-based Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with ....See Detailed Company Profile  and Dividend History.

▶ Celgene (CELG): The NASDAQ-listed Summit, New Jersey-based Celgene Corporation, incorporated on April 17, 1986, is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for ....See Detailed Company Profile  and Dividend History.

▶ Celgene (CELGZ): The NASDAQ-listed New Jersey, NJ-based ....See Detailed Company Profile  and Dividend History.

▶ Cellectar Biosciences (CLRB): The NASDAQ-listed Wisconsin, WI-based Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., incorporated on June 24, 1996, is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the ....See Detailed Company Profile  and Dividend History.

▶ Cellectar Biosciences (CLRBW): The NASDAQ-listed Wisconsin, WI-based ....See Detailed Company Profile  and Dividend History.

▶ Cellectar Biosciences (CLRBZ): The NASDAQ-listed Wisconsin, WI-based ....See Detailed Company Profile  and Dividend History.

▶ Celsion (CLSN): The NASDAQ-listed Maryland, MD-based Celsion Corporation (Celsion), incorporated on May 17, 2000, is an oncology drug development company. The Company is focused on developing a portfolio of cancer treatments, including directed chemotherapies, deoxyribonucleic acid ....See Detailed Company Profile  and Dividend History.

▶ Celyad SA (CYAD): The NASDAQ-listed Belgium-based Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat ....See Detailed Company Profile  and Dividend History.

▶ Cempra (CEMP): The NASDAQ-listed North Carolina, NC-based Cempra, Inc., incorporated on May 16, 2008, is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical ....See Detailed Company Profile  and Dividend History.

▶ Cerecor (CERC): The NASDAQ-listed Maryland, MD-based Cerecor, Inc., incorporated on January 31, 2011, is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company ....See Detailed Company Profile  and Dividend History.

▶ Cerecor (CERCW): The NASDAQ-listed Maryland, MD-based ....See Detailed Company Profile  and Dividend History.

▶ Cerecor (CERCZ): The NASDAQ-listed Baltimore, MD-based ....See Detailed Company Profile  and Dividend History.

▶ Cerulean Pharma (CERU): The NASDAQ-listed Massachusetts, MA-based Cerulean Pharma Inc., incorporated on November 28, 2005, is a clinical-stage, oncology-focused company. The Company applies its Dynamic Tumor Targeting platform to develop differentiated therapies. Its platform utilizes nanoparticle-drug conjugates ....See Detailed Company Profile  and Dividend History.

▶ Chembio Diagnostics (CEMI): The NASDAQ-listed New York, NY-based Chembio Diagnostics, Inc. (Chembio), incorporated on May 14, 1999, and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. ....See Detailed Company Profile  and Dividend History.

▶ ChemoCentryx (CCXI): The NASDAQ-listed California, CA-based ChemoCentryx, Inc., incorporated on November 8, 1996, is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of the ....See Detailed Company Profile  and Dividend History.

▶ Chiasma (CHMA): The NASDAQ-listed Massachusetts, MA-based Chiasma, Inc., incorporated on April 12, 2001, is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using ....See Detailed Company Profile  and Dividend History.

▶ Chimerix (CMRX): The NASDAQ-listed North Carolina, NC-based Chimerix, Inc., incorporated on April 7, 2000, is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, ....See Detailed Company Profile  and Dividend History.

▶ China Pharma (CPHI): The AMEX-listed China-based China Pharma Holdings, Inc., incorporated on January 28, 1999, is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical ....See Detailed Company Profile  and Dividend History.

▶ Clearside Biomedical (CLSD): The NASDAQ-listed Georgia, GA-based Clearside Biomedical, Inc., incorporated on May 26, 2011, is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Companys product candidates focus on ....See Detailed Company Profile  and Dividend History.

▶ Clovis Oncology (CLVS): The NASDAQ-listed Colorado, CO-based Clovis Oncology, Inc., incorporated on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The ....See Detailed Company Profile  and Dividend History.

▶ Collegium Pharmaceutical (COLL): The NASDAQ-listed Massachusetts, MA-based Collegium Pharmaceutical, Inc., incorporated on July 01, 2014, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for ....See Detailed Company Profile  and Dividend History.

▶ CoLucid Pharma (CLCD): The NASDAQ-listed Cambridge, MA-based ....See Detailed Company Profile  and Dividend History.

▶ Conatus Pharma (CNAT): The NASDAQ-listed San Diego, CA-based Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidates includ....See Detailed Company Profile  and Dividend History.

▶ Concert Pharma (CNCE): The NASDAQ-listed Massachusetts, MA-based Concert Pharmaceuticals, Inc., incorporated on April 12, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through ....See Detailed Company Profile  and Dividend History.

▶ Concordia International (CXRX): The NASDAQ-listed Canada-based Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into ....See Detailed Company Profile  and Dividend History.

▶ ContraFect (CFRX): The NASDAQ-listed New York, NY-based ContraFect Corporation, incorporated on March 5, 2008, is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious ....See Detailed Company Profile  and Dividend History.

▶ ContraFect (CFRXW): The NASDAQ-listed ....See Detailed Company Profile  and Dividend History.

▶ ContraVir Pharma (CTRV): The NASDAQ-listed New Jersey, NJ-based ContraVir Pharmaceuticals, Inc., incorporated on May 15, 2013, is a biopharmaceutical company. The Company focuses on the development of antiviral drugs for the treatment of Hepatitis B virus (HBV) infections. ....See Detailed Company Profile  and Dividend History.

▶ Corbus Pharma (CRBP): The NASDAQ-listed Massachusetts, MA-based Corbus Pharmaceuticals Holdings, Inc., incorporated on December 18, 2013, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and ....See Detailed Company Profile  and Dividend History.

▶ Corcept Therapeutics (CORT): The NASDAQ-listed California, CA-based Corcept Therapeutics Incorporated, incorporated on May 13, 1998, is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic ....See Detailed Company Profile  and Dividend History.

▶ Corium International (CORI): The NASDAQ-listed California, CA-based Corium International, Inc., incorporated on February 28, 2002, is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the ....See Detailed Company Profile  and Dividend History.

▶ CorMedix (CRMD): The AMEX-listed New Jersey, NJ-based CorMedix Inc., incorporated on July 28, 2006, is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment ....See Detailed Company Profile  and Dividend History.

▶ Corvus Pharma (CRVS): The NASDAQ-listed California, CA-based Corvus Pharmaceuticals, Inc., incorporated on January 27, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs ....See Detailed Company Profile  and Dividend History.

▶ CTI BioPharma (CTIC): The NASDAQ-listed Washington, WA-based CTI BioPharma Corp. (CTI), incorporated on September 4, 1991, is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers. The ....See Detailed Company Profile  and Dividend History.

▶ Cumberland Pharma (CPIX): The NASDAQ-listed Tennessee, TN-based Cumberland Pharmaceuticals Inc. (Cumberland), incorporated on January 7, 1999, is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company ....See Detailed Company Profile  and Dividend History.

▶ Cyclacel Pharma (CYCC): The NASDAQ-listed New Jersey, NJ-based Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci....See Detailed Company Profile  and Dividend History.

▶ Cyclacel Pharma (CYCCP): The NASDAQ-listed New Jersey, NJ-based Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci....See Detailed Company Profile  and Dividend History.

▶ CymaBay Therapeutics (CBAY): The NASDAQ-listed California, CA-based CymaBay Therapeutics, Inc., incorporated on October 5, 1988, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. ....See Detailed Company Profile  and Dividend History.

▶ Cytokinetics (CYTK): The NASDAQ-listed California, CA-based Cytokinetics, Incorporated, incorporated on August 5, 1997, is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases ....See Detailed Company Profile  and Dividend History.

▶ CytomX Therapeutics (CTMX): The NASDAQ-listed California, CA-based CytomX Therapeutics, Inc., incorporated on September 16, 2010, is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as ....See Detailed Company Profile  and Dividend History.

▶ DelMar Pharma (DMPI): The NASDAQ-listed Canada-based DelMar Pharmaceuticals, Inc., incorporated on June 24, 2009, is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials ....See Detailed Company Profile  and Dividend History.

▶ Depomed (DEPO): The NASDAQ-listed California, CA-based Depomed, Inc. incorporated on August 7, 1995, is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol ....See Detailed Company Profile  and Dividend History.

▶ Dermira (DERM): The NASDAQ-listed California, CA-based Dermira, Inc., incorporated on August 18, 2010, is a biopharmaceutical company. As of December 31, 2016, the Companys portfolio included three late-stage product candidates that target unmet needs and market ....See Detailed Company Profile  and Dividend History.

▶ Dicerna Pharma (DRNA): The NASDAQ-listed Massachusetts, MA-based Dicerna Pharmaceuticals, Inc., incorporated on October 24, 2006, is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based ....See Detailed Company Profile  and Dividend History.

▶ Diffusion Pharma (DFFN): The NASDAQ-listed Virginia, VA-based Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, incorporated on June 17, 2015, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The ....See Detailed Company Profile  and Dividend History.

▶ Dipexium Pharma (DPRX): The NASDAQ-listed ....See Detailed Company Profile  and Dividend History.

▶ Dr. Reddy's Laboratories (RDY): The NYSE-listed India-based Dr. Reddys Laboratories Limited, incorporated on February 24, 1984, is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and ....See Detailed Company Profile  and Dividend History.

▶ DURECT (DRRX): The NASDAQ-listed California, CA-based Durect Corporation, incorporated on February 6, 1998, is a biopharmaceutical company with research and development programs. The Companys research and development programs fall into two categories: new chemical entities derived ....See Detailed Company Profile  and Dividend History.

▶ Dynavax (DVAX): The NASDAQ-listed California, CA-based Dynavax Technologies Corporation (Dynavax), incorporated on November 6, 2000, is a clinical-stage immunotherapy company focused on leveraging the bodys innate and adaptive immune responses through toll-like receptor (TLR) stimulation. The ....See Detailed Company Profile  and Dividend History.

▶ Eagle Pharma (EGRX): The NASDAQ-listed New Jersey, NJ-based Eagle Pharmaceuticals, Inc., incorporated on January 2, 2007, is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The ....See Detailed Company Profile  and Dividend History.

▶ Edge Therapeutics (EDGE): The NASDAQ-listed New Jersey, NJ-based Edge Therapeutics, Inc., incorporated on January 22, 2009, is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management ....See Detailed Company Profile  and Dividend History.

▶ Egalet (EGLT): The NASDAQ-listed Pennsylvania, PA-based Egalet Corporation, incorporated on August 21, 2013, is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Companys products ....See Detailed Company Profile  and Dividend History.

▶ Eleven Biotherapeutics (EBIO): The NASDAQ-listed Massachusetts, MA-based Eleven Biotherapeutics, Inc., incorporated on February 25, 2008, is a preclinical-stage biopharmaceutical company. The Company applies its AMP-Rx platform to the discovery and development of protein therapeutics to treat diseases ....See Detailed Company Profile  and Dividend History.

▶ Eli Lilly (LLY): The NYSE-listed Indianapolis, Indiana-based Eli Lilly and Company, incorporated on January 17, 1901, is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and ....See Detailed Company Profile  and Dividend History.

▶ Emergent Biosolutions (EBS): The NYSE-listed Maryland, MD-based Emergent BioSolutions Inc., incorporated on December 19, 2003, is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations ....See Detailed Company Profile  and Dividend History.

▶ Enanta Pharma (ENTA): The NASDAQ-listed Massachusetts, MA-based Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for ....See Detailed Company Profile  and Dividend History.

▶ Endo International (ENDP): The NASDAQ-listed Ireland-based Endo International plc, incorporated on October 31, 2013, is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International ....See Detailed Company Profile  and Dividend History.

▶ Endocyte (ECYT): The NASDAQ-listed Indiana, IN-based Endocyte Inc. (Endocyte), incorporated on December 11, 2001, is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its ....See Detailed Company Profile  and Dividend History.

▶ Epizyme (EPZM): The NASDAQ-listed Massachusetts, MA-based Epizyme, Inc., incorporated on November 1, 2007, is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in ....See Detailed Company Profile  and Dividend History.

▶ Esperion Therapeutics (ESPR): The NASDAQ-listed Michigan, MI-based Esperion Therapeutics, Inc., incorporated on January 22, 2008, is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the ....See Detailed Company Profile  and Dividend History.

▶ ESSA Pharma (EPIX): The NASDAQ-listed Vancouver, BC-based ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.....See Detailed Company Profile  and Dividend History.

▶ Evoke Pharma (EVOK): The NASDAQ-listed California, CA-based Evoke Pharma, Inc., incorporated on January 29, 2007, is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. ....See Detailed Company Profile  and Dividend History.

▶ Eyegate Pharma (EYEG): The NASDAQ-listed Massachusetts, MA-based Eyegate Pharmaceuticals, Inc., incorporated on December 28, 2004, is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases ....See Detailed Company Profile  and Dividend History.

▶ Eyegate Pharma (EYEGW): The NASDAQ-listed Massachusetts, MA-based ....See Detailed Company Profile  and Dividend History.

▶ Fibrocell Science (FCSC): The NASDAQ-listed Pennsylvania, PA-based Fibrocell Science, Inc. (Fibrocell), incorporated on September 28, 1992, is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting ....See Detailed Company Profile  and Dividend History.

▶ FibroGen (FGEN): The NASDAQ-listed California, CA-based FibroGen, Inc., incorporated on September 29, 1993, is a science-based biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. ....See Detailed Company Profile  and Dividend History.

▶ Five Prime Therapeutics (FPRX): The NASDAQ-listed California, CA-based Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company has three product candidates in clinical development ....See Detailed Company Profile  and Dividend History.

▶ Flex Pharma (FLKS): The NASDAQ-listed Massachusetts, MA-based Flex Pharma, Inc., incorporated on February 26, 2014, is a biotechnology company that is developing treatments for nocturnal leg cramps, muscle cramps and spasms associated with severe neuromuscular conditions, and ....See Detailed Company Profile  and Dividend History.

▶ Flexion Therapeutics (FLXN): The NASDAQ-listed Massachusetts, MA-based Flexion Therapeutics, Inc., incorporated on November 5, 2007, is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with ....See Detailed Company Profile  and Dividend History.

▶ Fortress Biotech (FBIO): The NASDAQ-listed Massachusetts, MA-based Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of ....See Detailed Company Profile  and Dividend History.

▶ Forward Pharma AS (FWP): The NASDAQ-listed Denmark-based Forward Pharma Au002FS operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory ....See Detailed Company Profile  and Dividend History.

▶ Galapagos NV (GLPG): The NASDAQ-listed Belgium-based Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes novel medicines. Its clinical stage programs include filgotinib, which is in Phase III clinical trials for....See Detailed Company Profile  and Dividend History.

▶ Galectin Therapeutics (GALT): The NASDAQ-listed Massachusetts, MA-based Galectin Therapeutics Inc., incorporated on January 26, 2001, is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Companys drug ....See Detailed Company Profile  and Dividend History.

▶ Galectin Therapeutics (GALTU): The NASDAQ-listed ....See Detailed Company Profile  and Dividend History.

▶ Galectin Therapeutics (GALTW): The NASDAQ-listed ....See Detailed Company Profile  and Dividend History.

▶ Galena Biopharma (GALE): The NASDAQ-listed California, CA-based Galena Biopharma, Inc., incorporated on April 3, 2006, is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Companys development ....See Detailed Company Profile  and Dividend History.

▶ Galmed Pharma (GLMD): The NASDAQ-listed Israel-based Galmed Pharmaceuticals Ltd., incorporated on July 31, 2013, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver ....See Detailed Company Profile  and Dividend History.

▶ Gemphire Therapeutics (GEMP): The NASDAQ-listed Michigan, MI-based Gemphire Therapeutics Inc., incorporated on October 30, 2014, is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. ....See Detailed Company Profile  and Dividend History.

▶ GenVec (GNVC): The NASDAQ-listed Maryland, MD-based GenVec, Inc. (GenVec), incorporated on December 7, 1992, is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. ....See Detailed Company Profile  and Dividend History.

▶ Geron (GERN): The NASDAQ-listed California, CA-based Geron Corporation (Geron), incorporated on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, ....See Detailed Company Profile  and Dividend History.

▶ GlaxoSmithKline (GSK): The NYSE-listed Brentford, -based GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four ....See Detailed Company Profile  and Dividend History.

▶ Global Blood Therapeutics (GBT): The NASDAQ-listed California, CA-based Global Blood Therapeutics, Inc., incorporated on February 04, 2011, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company ....See Detailed Company Profile  and Dividend History.

▶ GlycoMimetics (GLYC): The NASDAQ-listed Maryland, MD-based GlycoMimetics, Inc., incorporated on April 4, 2003, is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and ....See Detailed Company Profile  and Dividend History.

▶ Grifols (GRFS): The NASDAQ-listed Spain-based Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company?ÇÖs activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses ....See Detailed Company Profile  and Dividend History.

▶ GTx (GTXI): The NASDAQ-listed Tennessee, TN-based GTx, Inc., incorporated on October 4, 2003, is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast ....See Detailed Company Profile  and Dividend History.

▶ GW Pharma (GWPH): The NASDAQ-listed United Kingdom-based GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Companys lead cannabinoid product candidate ....See Detailed Company Profile  and Dividend History.

▶ Heat Biologics (HTBX): The NASDAQ-listed North Carolina, NC-based Heat Biologics, Inc., incorporated on June 10, 2008, is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an ....See Detailed Company Profile  and Dividend History.

▶ Heron Therapeutics (HRTX): The NASDAQ-listed California, CA-based Heron Therapeutics, Inc., incorporated on February 5, 1987, is a biotechnology company. The Company is engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Companys product ....See Detailed Company Profile  and Dividend History.

▶ Horizon Pharma (HZNP): The NASDAQ-listed Ireland-based Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases....See Detailed Company Profile  and Dividend History.

▶ Hutchison China MediTech (HCM): The NASDAQ-listed Central, -based Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China ....See Detailed Company Profile  and Dividend History.

▶ iBio (IBIO): The AMEX-listed Delaware, DE-based iBio, Inc., incorporated on April 17, 2008, is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to ....See Detailed Company Profile  and Dividend History.

▶ Ignyta (RXDX): The NASDAQ-listed California, CA-based Ignyta, Inc., incorporated on August 29, 2011, is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion ....See Detailed Company Profile  and Dividend History.

▶ Immune Design (IMDZ): The NASDAQ-listed Washington, WA-based Immune Design Corp., a clinical-stage immunotherapy company, engages in the research and development of in vivo treatments for cancer. The company primarily develops oncology product candidates based ....See Detailed Company Profile  and Dividend History.

▶ Immune Pharma (IMNP): The NASDAQ-listed Massachusetts, MA-based Immune Pharmaceuticals Inc., incorporated on March 9, 1993, is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation ....See Detailed Company Profile  and Dividend History.

▶ ImmunoCellular Therapeutics (IMUC): The AMEX-listed California, CA-based ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Companys cancer immunotherapies target cancer ....See Detailed Company Profile  and Dividend History.

▶ ImmunoGen (IMGN): The NASDAQ-listed Massachusetts, MA-based ImmunoGen, Inc., incorporated on March 27, 1981, is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. The Company is engaged in the discovery ....See Detailed Company Profile  and Dividend History.

▶ Impax Laboratories (IPXL): The NASDAQ-listed California, CA-based Impax Laboratories, Inc., incorporated on March 23, 1995, is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition ....See Detailed Company Profile  and Dividend History.

▶ Imprimis Pharma (IMMY): The NASDAQ-listed California, CA-based Imprimis Pharmaceuticals, Inc. (Imprimis), incorporated on January 11, 2006, is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies ....See Detailed Company Profile  and Dividend History.

▶ Infinity Pharma (INFI): The NASDAQ-listed California, CA-based Infinity Pharmaceuticals, Inc., incorporated on May 11, 2000, is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops ....See Detailed Company Profile  and Dividend History.

▶ Innocoll (INNL): The NASDAQ-listed Ireland-based Innocoll Holdings Public Limited Company, incorporated on May 28, 2014, is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of ....See Detailed Company Profile  and Dividend History.

▶ Innoviva (INVA): The NASDAQ-listed California, CA-based Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization ....See Detailed Company Profile  and Dividend History.

▶ Inotek Pharma (ITEK): The NASDAQ-listed Massachusetts, MA-based Inotek Pharmaceuticals Corporation, incorporated on July 7, 1999, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases ....See Detailed Company Profile  and Dividend History.

▶ Insmed (INSM): The NASDAQ-listed New Jersey, NJ-based Insmed Incorporated, incorporated on March 21, 2013, is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. The Companys lead product ....See Detailed Company Profile  and Dividend History.

▶ Insys Therapeutics (INSY): The NASDAQ-listed Arizona, AZ-based Insys Therapeutics, Inc., incorporated on June 15, 1990, is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. Subsys is the Companys marketed product. Subsys is ....See Detailed Company Profile  and Dividend History.

▶ Intec Pharma (NTEC): The NASDAQ-listed Jerusalem, -based Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery syst....See Detailed Company Profile  and Dividend History.

▶ Intellipharmaceutics International (IPCI): The NASDAQ-listed Canada-based Intellipharmaceutics International Inc., incorporated on October 22, 2009, is a pharmaceutical company. The Company is engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. ....See Detailed Company Profile  and Dividend History.

▶ Intercept Pharma (ICPT): The NASDAQ-listed New York, NY-based Intercept Pharmaceuticals, Inc., incorporated on September 4, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The ....See Detailed Company Profile  and Dividend History.

▶ Intra-Cellular Therapies (ITCI): The NASDAQ-listed New York, NY-based Intra-Cellular Therapies, Inc. (ITI), incorporated on August 29, 2012, is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved ....See Detailed Company Profile  and Dividend History.

▶ Ionis Pharma (IONS): The NASDAQ-listed California, CA-based Ionis Pharmaceuticals, Inc., incorporated on March 25, 1991, is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of ....See Detailed Company Profile  and Dividend History.

▶ Ironwood Pharma (IRWD): The NASDAQ-listed Massachusetts, MA-based Ironwood Pharmaceuticals, Inc., incorporated on January 5, 1998, is a biotechnology company. The Company is advancing product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS ....See Detailed Company Profile  and Dividend History.

▶ Jaguar Animal Health (JAGX): The NASDAQ-listed California, CA-based Jaguar Animal Health, Inc., incorporated on June 6, 2013, is an animal health company. The Company is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, ....See Detailed Company Profile  and Dividend History.

▶ Jazz Pharma (JAZZ): The NASDAQ-listed Ireland-based Jazz Pharmaceuticals Public Limited Company, incorporated on March 15, 2005, is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company ....See Detailed Company Profile  and Dividend History.

▶ Johnson and Johnson (JNJ): The NYSE-listed New Brunswick, New Jersey-based Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharma....See Detailed Company Profile  and Dividend History.

▶ Juniper Pharma (JNP): The NASDAQ-listed New Jersey, NJ-based Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., incorporated on December 30, 1986, is a womens health therapeutic company focused on developing intra-vaginal therapeutics that addresses the medical needs in womens ....See Detailed Company Profile  and Dividend History.

▶ Kadmon (KDMN): The NYSE-listed New York, NY-based Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of ....See Detailed Company Profile  and Dividend History.

▶ KalVista Pharma (KALV): The NASDAQ-listed United Kingdom-based KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., incorporated on March 26, 2004, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule ....See Detailed Company Profile  and Dividend History.

▶ Kamada (KMDA): The NASDAQ-listed Rehovot, -based Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, inclu....See Detailed Company Profile  and Dividend History.

▶ Karyopharm Therapeutics (KPTI): The NASDAQ-listed Massachusetts, MA-based Karyopharm Therapeutics Inc., incorporated on December 22, 2008, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and ....See Detailed Company Profile  and Dividend History.

▶ KemPharm (KMPH): The NASDAQ-listed Iowa, IA-based KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ....See Detailed Company Profile  and Dividend History.

▶ Keryx BioPharma (KERX): The NASDAQ-listed New York, NY-based Keryx Biopharmaceuticals, Inc., incorporated on October 22, 1998, is a biopharmaceutical company, which is focused on the development of medicines for people with renal disease. The Company is engaged in ....See Detailed Company Profile  and Dividend History.

▶ Kindred Biosciences (KIN): The NASDAQ-listed California, CA-based Kindred Biosciences, Inc., incorporated on September 25, 2012, is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Companys product pipeline consists of small molecules ....See Detailed Company Profile  and Dividend History.

▶ Kitov Pharma (KTOV): The NASDAQ-listed Tel Aviv, -based Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and....See Detailed Company Profile  and Dividend History.

▶ Kitov Pharma (KTOVW): The NASDAQ-listed Israel-based ....See Detailed Company Profile  and Dividend History.

▶ Kura Oncology (KURA): The NASDAQ-listed California, CA-based Kura Oncology, Inc., incorporated on November 16, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and ....See Detailed Company Profile  and Dividend History.

▶ Lannett Co (LCI): The NYSE-listed Pennsylvania, PA-based Lannett Company, Inc., incorporated on December 3, 1991, develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of ....See Detailed Company Profile  and Dividend History.

▶ Lexicon Pharma (LXRX): The NASDAQ-listed Texas, TX-based Lexicon Pharmaceuticals, Inc., incorporated on July 7, 1995, is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. The Companys drug programs ....See Detailed Company Profile  and Dividend History.

▶ Lifevantage (LFVN): The NASDAQ-listed Utah, UT-based LifeVantage Corporation, incorporated on June 10, 1988, is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides ....See Detailed Company Profile  and Dividend History.

▶ Ligand Pharma (LGND): The NASDAQ-listed California, CA-based Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company ....See Detailed Company Profile  and Dividend History.

▶ Lipocine (LPCN): The NASDAQ-listed Utah, UT-based Lipocine Inc., incorporated on October 13, 2011, is a specialty pharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products in ....See Detailed Company Profile  and Dividend History.

▶ Loxo Oncology (LOXO): The NASDAQ-listed Connecticut, CT-based Loxo Oncology, Inc., incorporated on May 9, 2013, is a biopharmaceutical company. The Company is focused on development of medicines for patients with genetically defined cancers. The Companys pipeline focuses ....See Detailed Company Profile  and Dividend History.

▶ MabVax Therapeutics (MBVX): The NASDAQ-listed California, CA-based MabVax Therapeutics Holdings, Inc., incorporated on October 20, 1988, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of human monoclonal antibody products and ....See Detailed Company Profile  and Dividend History.

▶ MacroGenics (MGNX): The NASDAQ-listed Maryland, MD-based MacroGenics, Inc., incorporated on August 14, 2000, is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune ....See Detailed Company Profile  and Dividend History.

▶ Madrigal Pharma (MDGL): The NASDAQ-listed Massachusetts, MA-based Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., incorporated on March 10, 2000, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the ....See Detailed Company Profile  and Dividend History.

▶ Mallinckrodt (MNK): The NYSE-listed Dublin, Ireland-based Mallinckrodt public limited company, incorporated on January 9, 2013, develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such ....See Detailed Company Profile  and Dividend History.

▶ MannKind (MNKD): The NASDAQ-listed California, CA-based MannKind Corporation (MannKind), incorporated on February 14, 1991, is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. The ....See Detailed Company Profile  and Dividend History.

▶ Marinus Pharma (MRNS): The NASDAQ-listed Pennsylvania, PA-based Marinus Pharmaceuticals, Inc., incorporated on August 14, 2003, is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product ....See Detailed Company Profile  and Dividend History.

▶ Mast Therapeutics (MSTX): The NYSE-listed California, CA-based ....See Detailed Company Profile  and Dividend History.

▶ MediciNova (MNOV): The NASDAQ-listed La Jolla, CA-based MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is dev....See Detailed Company Profile  and Dividend History.

▶ MEI Pharma (MEIP): The NASDAQ-listed California, CA-based MEI Pharma, Inc., a pharmaceutical company, focuses on the clinical development of novel therapies for the treatment of cancer. The company's clinical drug candidate includes Pracinostat, an oral avai....See Detailed Company Profile  and Dividend History.

▶ Merck (MRK): The NYSE-listed Whitehouse Station, New Jersey-based Merck & Co., Inc., incorporated in 1970, is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates ....See Detailed Company Profile  and Dividend History.

▶ Merrimack Pharma (MACK): The NASDAQ-listed Massachusetts, MA-based Merrimack Pharmaceuticals, Inc., incorporated on July 6, 2010, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing medicines consisting of therapeutics paired with companion diagnostics for ....See Detailed Company Profile  and Dividend History.

▶ Merus (MRUS): The NASDAQ-listed Netherlands-based Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics ....See Detailed Company Profile  and Dividend History.

▶ Merus Labs International (MSLI): The NASDAQ-listed Canada-based 100 Wellington St. West Suite 21....See Detailed Company Profile  and Dividend History.

▶ Midatech Pharma (MTP): The NASDAQ-listed Abingdon, -based Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates throug....See Detailed Company Profile  and Dividend History.

▶ Minerva Neurosciences (NERV): The NASDAQ-listed Massachusetts, MA-based Minerva Neurosciences, Inc., incorporated on April 23, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat ....See Detailed Company Profile  and Dividend History.

▶ Mirati Therapeutics (MRTX): The NASDAQ-listed California, CA-based Mirati Therapeutics, Inc., incorporated on April 29, 2013, is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Companys clinical pipeline consists ....See Detailed Company Profile  and Dividend History.

▶ Mirna Therapeutics (MIRN): The NASDAQ-listed Texas, TX-based Mirna Therapeutics, Inc., incorporated on December 20, 2007, is a clinical-stage biopharmaceutical company developing a pipeline of micro ribonucleic acid (RNA)-based oncology therapeutics. The Company is developing mimics of naturally ....See Detailed Company Profile  and Dividend History.

▶ Moleculin Biotech (MBRX): The NASDAQ-listed Texas, TX-based Moleculin Biotech, Inc., incorporated on July 28, 2015, is a preclinical and clinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. The Companys lead drug ....See Detailed Company Profile  and Dividend History.

▶ Motif Bio (MTFB): The NASDAQ-listed New York, NY-based Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and l....See Detailed Company Profile  and Dividend History.

▶ Motif Bio (MTFBW): The NASDAQ-listed New York, NY-based ....See Detailed Company Profile  and Dividend History.

▶ Mylan (MYL): The NASDAQ-listed Amsterdam, Netherlands-based Mylan N.V., incorporated on July 7, 2014, is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range ....See Detailed Company Profile  and Dividend History.

▶ MyoKardia (MYOK): The NASDAQ-listed California, CA-based MyoKardia, Inc., incorporated on June 8, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure ....See Detailed Company Profile  and Dividend History.

▶ MYOS RENS Technology (MYOS): The NASDAQ-listed New Jersey, NJ-based MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, incorporated on April 11, 2007, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization ....See Detailed Company Profile  and Dividend History.

▶ Myovant Sciences (MYOV): The NYSE-listed Delaware, DE-based Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for women?ÇÖs health diseases and other endocrine-related disorders. Its main product candidate is Relugolix. Relugolix is ....See Detailed Company Profile  and Dividend History.

▶ Nabriva Therapeutics AG (NBRV): The NASDAQ-listed Austria-based Nabriva Therapeutics AG is an Austria-based clinical-stage biopharmaceutical company engaged in the research and development of antibiotics to treat infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic for ....See Detailed Company Profile  and Dividend History.

▶ Nature's Sunshine Products (NATR): The NASDAQ-listed Utah, UT-based Natures Sunshine Products, Inc. (NSP), incorporated on November 26, 1976, together with its subsidiaries, is a natural health and wellness company. The Company is engaged in the manufacturing and direct ....See Detailed Company Profile  and Dividend History.

▶ Nektar Therapeutics (NKTR): The NASDAQ-listed California, CA-based Nektar Therapeutics, incorporated on June 3, 1998, is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Companys research and development pipeline of ....See Detailed Company Profile  and Dividend History.

▶ Neos Therapeutics (NEOS): The NASDAQ-listed Texas, TX-based Neos Therapeutics, Inc., incorporated on June 15, 2009, is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. The ....See Detailed Company Profile  and Dividend History.

▶ Neothetics (NEOT): The NASDAQ-listed California, CA-based Neothetics, Inc., incorporated on February 1, 2007, is a clinical-stage specialty pharmaceutical company. The Company develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on ....See Detailed Company Profile  and Dividend History.

▶ Neptune and Bioresources (NEPT): The NASDAQ-listed Canada-based Neptune Technologies & Bioressources Inc. is a solution provider of omega-3s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged ....See Detailed Company Profile  and Dividend History.

▶ NeuroDerm (NDRM): The NASDAQ-listed Israel-based NeuroDerm Ltd., incorporated on March 18, 2003, is a clinical-stage pharmaceutical company. The Company is engaged in developing treatments for central nervous system (CNS) disorders, primarily Parkinsons disease, as well ....See Detailed Company Profile  and Dividend History.

▶ NewLink Genetics (NLNK): The NASDAQ-listed Iowa, IA-based NewLink Genetics Corporation (NewLink), incorporated on June 4, 1999, is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Companys portfolio ....See Detailed Company Profile  and Dividend History.

▶ Nexvet Biopharma (NVET): The NASDAQ-listed Ireland-based Nexvet Biopharma public limited company, incorporated on August 14, 2014, is a clinical-stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing species-specific biologics. ....See Detailed Company Profile  and Dividend History.

▶ Nivalis Therapeutics (NVLS): The NASDAQ-listed Colorado, CO-based Nivalis Therapeutics, Inc., incorporated on March 30, 2007, is a pharmaceutical company. The Company focuses on the discovery and development of product candidates for patients with cystic fibrosis (CF). Its ....See Detailed Company Profile  and Dividend History.

▶ NovaBay Pharma (NBY): The AMEX-listed California, CA-based NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., incorporated on April 19, 2010, is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription ....See Detailed Company Profile  and Dividend History.

▶ Novan (NOVN): The NASDAQ-listed North Carolina, NC-based Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its ....See Detailed Company Profile  and Dividend History.

▶ Novartis AG (NVS): The NYSE-listed Switzerland-based Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare....See Detailed Company Profile  and Dividend History.

▶ Novelion Therapeutics (NVLN): The NASDAQ-listed Canada-based Novelion Therapeutics Inc, formerly QLT Inc., incorporated in 1981, is a biotechnology company. The Company is focused on the development and commercialization of ocular products that address the unmet medical ....See Detailed Company Profile  and Dividend History.

▶ Novo Nordisk (NVO): The NYSE-listed Denmark-based Novo Nordisk A S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Bi....See Detailed Company Profile  and Dividend History.

▶ Novogen (NVGN): The NASDAQ-listed Australia-based Novogen Limited (Novogen), incorporated on March 18, 1994, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. ....See Detailed Company Profile  and Dividend History.

▶ Oasmia Pharmaceutical AB (OASM): The NASDAQ-listed Uppsala, -based Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations and drug-delivery sys....See Detailed Company Profile  and Dividend History.

▶ Ocera Therapeutics (OCRX): The NASDAQ-listed North Carolina, NC-based Ocera Therapeutics, Inc., incorporated on January 12, 1998, is a clinical-stage biopharmaceutical company. The Company is focused on acute and chronic orphan liver diseases. The Company is focused on the ....See Detailed Company Profile  and Dividend History.

▶ Ocular Therapeutix (OCUL): The NASDAQ-listed Massachusetts, MA-based Ocular Therapeutix, Inc., incorporated on September 12, 2006, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye ....See Detailed Company Profile  and Dividend History.

▶ Ohr Pharma (OHRP): The NASDAQ-listed New York, NY-based Ohr Pharmaceutical, Inc., incorporated on May 8, 2014, is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Companys development ....See Detailed Company Profile  and Dividend History.

▶ Omeros (OMER): The NASDAQ-listed Washington, WA-based Omeros Corporation, incorporated on June 16, 1994, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan ....See Detailed Company Profile  and Dividend History.

▶ OncoMed Pharma (OMED): The NASDAQ-listed California, CA-based OncoMed Pharmaceuticals, Inc. (OncoMed), incorporated on July 19, 2004, is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing therapeutics that address the fundamental biology driving cancers growth, ....See Detailed Company Profile  and Dividend History.

▶ Onconova Therapeutics (ONTX): The NASDAQ-listed Pennsylvania, PA-based Onconova Therapeutics, Inc., incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering ....See Detailed Company Profile  and Dividend History.

▶ Onconova Therapeutics (ONTXW): The NASDAQ-listed Pennsylvania, PA-based ....See Detailed Company Profile  and Dividend History.

▶ OncoSec Medical (ONCS): The NASDAQ-listed California, CA-based OncoSec Medical Incorporated, incorporated on February 8, 2008, is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an ....See Detailed Company Profile  and Dividend History.

▶ Opexa Therapeutics (OPXA): The NASDAQ-listed Texas, TX-based Opexa Therapeutics, Inc. (Opexa), incorporated on March 15, 1991, is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various ....See Detailed Company Profile  and Dividend History.

▶ Opexa Therapeutics (OPXAW): The NASDAQ-listed Texas, TX-based ....See Detailed Company Profile  and Dividend History.

▶ Ophthotech (OPHT): The NASDAQ-listed New York, NY-based Ophthotech Corporation, incorporated on January 5, 2007, is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of ....See Detailed Company Profile  and Dividend History.

▶ Opko Health (OPK): The NASDAQ-listed Florida, FL-based OPKO Health, Inc., incorporated on November 18, 1991, is a diversified healthcare company. The Companys segments include Pharmaceutical, Diagnostics and Corporate. The pharmaceutical segment consists of the pharmaceutical operations in ....See Detailed Company Profile  and Dividend History.

▶ Oragenics (OGEN): The AMEX-listed Florida, FL-based Oragenics, Inc., incorporated on November 6, 1996, develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The ....See Detailed Company Profile  and Dividend History.

▶ Oramed Pharma (ORMP): The NASDAQ-listed Israel-based Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. OramedĈs flagship product, an orally ingestible insulin capsule in ....See Detailed Company Profile  and Dividend History.

▶ Orexigen Therapeutics (OREX): The NASDAQ-listed California, CA-based Orexigen Therapeutics, Inc., incorporated on September 12, 2002, is a biopharmaceutical company. The Company is focused on the treatment of obesity. The Companys product, Contrave, is approved in the United ....See Detailed Company Profile  and Dividend History.

▶ Otonomy (OTIC): The NASDAQ-listed California, CA-based Otonomy, Inc., incorporated on May 6, 2008, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Companys ....See Detailed Company Profile  and Dividend History.

▶ OvaScience (OVAS): The NASDAQ-listed Massachusetts, MA-based OvaScience, Inc., incorporated on April 5, 2011, is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Companys ....See Detailed Company Profile  and Dividend History.

▶ Pacira Pharma (PCRX): The NASDAQ-listed New Jersey, NJ-based Pacira Pharmaceuticals, Inc., incorporated on December 22, 2006, is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on ....See Detailed Company Profile  and Dividend History.

▶ Pain Therapeutics (PTIE): The NASDAQ-listed California, CA-based Pain Therapeutics, Inc. develops drugs for nervous system disorders in the United States. The company's lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone to tr....See Detailed Company Profile  and Dividend History.

▶ Palatin (PTN): The AMEX-listed New Jersey, NJ-based Palatin Technologies, Inc., incorporated on November 21, 1986, is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet ....See Detailed Company Profile  and Dividend History.

▶ Paratek Pharma (PRTK): The NASDAQ-listed Boston, MA-based Paratek Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon tetracycline chemistry in the United States. Its lead produ....See Detailed Company Profile  and Dividend History.

▶ Patheon (PTHN): The NYSE-listed Netherlands-based Patheon N.V., incorporated on December 24, 2013, is a provider of outsourced pharmaceutical development and manufacturing services. The Companys segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and ....See Detailed Company Profile  and Dividend History.

▶ Peregrine Pharma (PPHM): The NASDAQ-listed California, CA-based Peregrine Pharmaceuticals, Inc. (Peregrine), incorporated on September 25, 1996, is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal ....See Detailed Company Profile  and Dividend History.

▶ Peregrine Pharma (PPHMP): The NASDAQ-listed California, CA-based Peregrine Pharmaceuticals, Inc. (Peregrine), incorporated on September 25, 1996, is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal ....See Detailed Company Profile  and Dividend History.

▶ Pernix Therapeutics (PTX): The NASDAQ-listed Texas, TX-based Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The Company focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It focuses on underserved therapeutic areas, ....See Detailed Company Profile  and Dividend History.

▶ Perrigo (PRGO): The NYSE-listed Dublin, Ireland-based Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Companys segments include Consumer Healthcare (CHC), ....See Detailed Company Profile  and Dividend History.

▶ Pfenex (PFNX): The AMEX-listed California, CA-based Pfenex Inc., incorporated on November 19, 2009, is a clinical-stage biotechnology company. The Company is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other ....See Detailed Company Profile  and Dividend History.

▶ Pfizer (PFE): The NYSE-listed New York, NY-based Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio ....See Detailed Company Profile  and Dividend History.

▶ PharmAthene (PIP): The AMEX-listed Iowa, IA-based Pharmathene, Inc. (Pharmathene), incorporated on April 25, 2005, is a biodefense company. The Company focuses in development of medical counter measures against biological and chemical threats. The Company is involved ....See Detailed Company Profile  and Dividend History.

▶ PhaseRx (PZRX): The NASDAQ-listed Washington, WA-based PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Companys initial product development focus is on urea cycle ....See Detailed Company Profile  and Dividend History.

▶ Phibro Animal Health (PAHC): The NASDAQ-listed New Jersey, NJ-based Phibro Animal Health Corporation (Phibro), incorporated on January 27, 2014, is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, ....See Detailed Company Profile  and Dividend History.

▶ Portola Pharma (PTLA): The NASDAQ-listed California, CA-based Portola Pharmaceuticals, Inc., incorporated on September 2, 2003, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic ....See Detailed Company Profile  and Dividend History.

▶ Prana Biotechnology (PRAN): The NASDAQ-listed Australia-based Prana Biotechnology Limited, incorporated on November 11, 1997, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the ....See Detailed Company Profile  and Dividend History.

▶ Prestige Brand (PBH): The NYSE-listed New York, NY-based Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, ....See Detailed Company Profile  and Dividend History.

▶ Prima BioMed (PBMD): The NASDAQ-listed Australia-based Prima BioMed Ltd is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The ....See Detailed Company Profile  and Dividend History.

▶ Progenics Pharma (PGNX): The NASDAQ-listed New York, NY-based Progenics Pharmaceuticals, Inc., incorporated on December 1, 1986, is engaged in developing medicines and other products for targeting and treating cancer. The Companys pipeline includes therapeutic agents designed to target ....See Detailed Company Profile  and Dividend History.

▶ ProPhase Labs (PRPH): The NASDAQ-listed Pennsylvania, PA-based ProPhase Labs, Inc., incorporated on August 24, 1989, manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter ....See Detailed Company Profile  and Dividend History.

▶ ProQR Therapeutics (PRQR): The NASDAQ-listed Netherlands-based ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of Ribonucleic Acid (RNA)-based therapeutics for the ....See Detailed Company Profile  and Dividend History.

▶ Protagonist Therapeutics (PTGX): The NASDAQ-listed California, CA-based Protagonist Therapeutics, Inc., incorporated on August 22, 2006, is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant ....See Detailed Company Profile  and Dividend History.

▶ Proteostasis Therapeutics (PTI): The NASDAQ-listed Massachusetts, MA-based Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set ....See Detailed Company Profile  and Dividend History.

▶ Prothena (PRTA): The NASDAQ-listed California, CA-based Prothena Corporation Public Limited Company, incorporated on September 26, 2012, is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment ....See Detailed Company Profile  and Dividend History.

▶ PTC Therapeutics (PTCT): The NASDAQ-listed New Jersey, NJ-based PTC Therapeutics, Inc., incorporated on March 31, 1998, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid ....See Detailed Company Profile  and Dividend History.

▶ Pulmatrix (PULM): The NASDAQ-listed Massachusetts, MA-based Pulmatrix, Inc., incorporated on September 25, 2013, is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company?ÇÖs product pipeline is focused on advancing treatments ....See Detailed Company Profile  and Dividend History.

▶ Puma Biotechnology (PBYI): The NASDAQ-listed California, CA-based Puma Biotechnology, Inc., incorporated on September 15, 2010, is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on ....See Detailed Company Profile  and Dividend History.

▶ Ra Pharma (RARX): The NASDAQ-listed Massachusetts, MA-based Ra Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutics for diseases of complement dysregulation and a range of orphan indications. It ....See Detailed Company Profile  and Dividend History.

▶ Radius Health (RDUS): The NASDAQ-listed Massachusetts, MA-based Radius Health, Inc., incorporated on February 4, 2008, is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The ....See Detailed Company Profile  and Dividend History.

▶ Reata Pharma (RETA): The NASDAQ-listed Texas, TX-based Reata Pharmaceuticals, Inc., incorporated on March 11, 2002, is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory ....See Detailed Company Profile  and Dividend History.

▶ Recro Pharma (REPH): The NASDAQ-listed Pennsylvania, PA-based Recro Pharma, Inc., incorporated on November 15, 2007, is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing products for hospitals and ambulatory care settings that is developing ....See Detailed Company Profile  and Dividend History.

▶ Redhill Biopharma (RDHL): The NASDAQ-listed Israel-based RedHill Biopharma Ltd., incorporated on August 3, 2009, is a biopharmaceutical company. The Company is focused on the development and commercialization of clinical-stage, orally-administered, small molecule drugs for the treatment ....See Detailed Company Profile  and Dividend History.

▶ Regeneron Pharma (REGN): The NASDAQ-listed New York, NY-based Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes ....See Detailed Company Profile  and Dividend History.

▶ Regulus Therapeutics (RGLS): The NASDAQ-listed California, CA-based Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing drugs that target microribonucleic acid (microRNAs) to treat a range of diseases. The ....See Detailed Company Profile  and Dividend History.

▶ Reliv' International (RELV): The NASDAQ-listed Missouri, MO-based Reliv International, Inc., incorporated on April 12, 1999, is a developer, manufacturer and marketer of a line of nutritional supplements addressing nutrition, specific wellness needs, weight management and sports nutrition. ....See Detailed Company Profile  and Dividend History.

▶ Retrophin (RTRX): The NASDAQ-listed California, CA-based Retrophin, Inc. (Retrophin), incorporated on February 7, 2008, is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic ....See Detailed Company Profile  and Dividend History.

▶ Revance Therapeutics (RVNC): The NASDAQ-listed California, CA-based Revance Therapeutics, Inc., incorporated on August 10, 1999, is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic ....See Detailed Company Profile  and Dividend History.

▶ Rexahn Pharma (RNN): The AMEX-listed Maryland, MD-based Rexahn Pharmaceuticals, Inc., incorporated on January 14, 2005, is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of treatments for cancer. The Companys clinical-stage drug candidates in ....See Detailed Company Profile  and Dividend History.

▶ Rigel Pharma (RIGL): The NASDAQ-listed California, CA-based Rigel Pharmaceuticals, Inc., incorporated on June 14, 1996, is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted drugs in the therapeutic areas of ....See Detailed Company Profile  and Dividend History.

▶ Ritter Pharma (RTTR): The NASDAQ-listed California, CA-based Ritter Pharmaceuticals, Inc., incorporated on October 16, 2008, develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Companys segment is focusing on the development and ....See Detailed Company Profile  and Dividend History.

▶ Rosetta Genomics (ROSG): The NASDAQ-listed Israel-based Rosetta Genomics Ltd., incorporated on March 9, 2000, is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) ....See Detailed Company Profile  and Dividend History.

▶ RXi Pharma (RXII): The NASDAQ-listed Massachusetts, MA-based RXi Pharmaceuticals Corporation, incorporated on October 8, 2011, is a clinical-stage ribonucleic acid (RNA) interference (RNAi) company developing therapeutics in dermatology and ophthalmology that address unmet medical needs. The Companys ....See Detailed Company Profile  and Dividend History.

▶ RXi Pharma (RXIIW): The NASDAQ-listed Massachusetts, MA-based ....See Detailed Company Profile  and Dividend History.

▶ Sage Therapeutics (SAGE): The NASDAQ-listed Massachusetts, MA-based SAGE Therapeutics, Inc., incorporated on April 16, 2010, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The ....See Detailed Company Profile  and Dividend History.

▶ Sanofi (GCVRZ): The NASDAQ-listed Paris, France-based Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; ....See Detailed Company Profile  and Dividend History.

▶ Sanofi (SNY): The NYSE-listed France-based Sanofi, incorporated on May 11, 1994, is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Companys segments are ....See Detailed Company Profile  and Dividend History.

▶ Sarepta Therapeutics (SRPT): The NASDAQ-listed Massachusetts, MA-based Sarepta Therapeutics, Inc., incorporated on June 5, 2013, is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of ....See Detailed Company Profile  and Dividend History.

▶ SciClone Pharma (SCLN): The NASDAQ-listed California, CA-based SciClone Pharmaceuticals, Inc. (SciClone), incorporated on June 26, 2003, is a pharmaceutical company. The Companys product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Companys business is ....See Detailed Company Profile  and Dividend History.

▶ SCYNEXIS (SCYX): The NASDAQ-listed New Jersey, NJ-based SCYNEXIS, Inc., incorporated on November 4, 1999, is a pharmaceutical company, which is engaged in the discovery, development and commercialization of anti-infectives to address unmet therapeutic needs. The Company is ....See Detailed Company Profile  and Dividend History.

▶ Selecta Biosciences (SELB): The NASDAQ-listed Massachusetts, MA-based Selecta Biosciences, Inc., incorporated on December 10, 2007, is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are ....See Detailed Company Profile  and Dividend History.

▶ Seres Therapeutics (MCRB): The NASDAQ-listed Massachusetts, MA-based Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic ....See Detailed Company Profile  and Dividend History.

▶ Shire (SHPG): The NASDAQ-listed Ireland-based Shire plc, incorporated on January 28, 2008, is a biotech company focused on serving people with rare diseases and other specialized conditions. The Companys segment is engaged in research, development, ....See Detailed Company Profile  and Dividend History.

▶ Sierra Oncology (SRRA): The NASDAQ-listed Canada-based Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., incorporated on May 8, 2003, is a clinical-stage drug development company. The Company?ÇÖs lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor ....See Detailed Company Profile  and Dividend History.

▶ Sinovac Biotech (SVA): The NASDAQ-listed China-based Sinovac Biotech Ltd. (Sinovac), incorporated on March 1, 1999, is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines ....See Detailed Company Profile  and Dividend History.

▶ Soligenix (SNGX): The NASDAQ-listed New Jersey, NJ-based Soligenix, Inc. (Soligenix), incorporated on January 16, 1987, is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through ....See Detailed Company Profile  and Dividend History.

▶ Soligenix (SNGXW): The NASDAQ-listed New Jersey, NJ-based ....See Detailed Company Profile  and Dividend History.

▶ Sonoma Pharma (SNOA): The NASDAQ-listed California, CA-based Sonoma Pharmaceuticals, Inc., formerly Oculus Innovative Sciences, Inc., incorporated on November 20, 2006, is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ....See Detailed Company Profile  and Dividend History.

▶ Sonoma Pharma (SNOAW): The NASDAQ-listed California, CA-based ....See Detailed Company Profile  and Dividend History.

▶ Spectrum Pharma (SPPI): The NASDAQ-listed California, CA-based Spectrum Pharmaceuticals, Inc., incorporated on November 18, 2002, is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has a product portfolio ....See Detailed Company Profile  and Dividend History.

▶ Spring Bank Pharma (SBPH): The NASDAQ-listed Massachusetts, MA-based Spring Bank Pharmaceuticals, Inc., incorporated on May 12, 2008, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its ....See Detailed Company Profile  and Dividend History.

▶ SteadyMed (STDY): The NASDAQ-listed Israel-based SteadyMed Ltd., incorporated on June 15, 2005, is a specialty pharmaceutical company. The Company is focused on the development and commercialization of various therapeutic product candidates to treat orphan and ....See Detailed Company Profile  and Dividend History.

▶ Stellar Biotechnologies (SBOT): The NASDAQ-listed Port Hueneme, CA-based Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North Ameri....See Detailed Company Profile  and Dividend History.

▶ Stemline Therapeutics (STML): The NASDAQ-listed New York, NY-based Stemline Therapeutics, Inc., incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage ....See Detailed Company Profile  and Dividend History.

▶ Strongbridge Biopharma (SBBP): The NASDAQ-listed Pennsylvania, PA-based Strongbridge Biopharma plc, incorporated on May 26, 2015, is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. ....See Detailed Company Profile  and Dividend History.

▶ Sucampo Pharma (SCMP): The NASDAQ-listed Maryland, MD-based Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ....See Detailed Company Profile  and Dividend History.

▶ Summit Therapeutics (SMMT): The NASDAQ-listed Abingdon, -based Summit Therapeutics plc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel medicines to treat rare and infectious diseases in the United Kingdom and North Americ....See Detailed Company Profile  and Dividend History.

▶ Sunesis Pharma (SNSS): The NASDAQ-listed California, CA-based Sunesis Pharmaceuticals, Inc., incorporated on February 10, 1998, is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of ....See Detailed Company Profile  and Dividend History.

▶ Supernus Pharma (SUPN): The NASDAQ-listed Maryland, MD-based Supernus Pharmaceuticals, Inc., incorporated on March 30, 2005, is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company offers ....See Detailed Company Profile  and Dividend History.

▶ Syndax Pharma (SNDX): The NASDAQ-listed Massachusetts, MA-based Syndax Pharmaceuticals, Inc., incorporated on October 11, 2005, is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company?ÇÖs product candidate, ....See Detailed Company Profile  and Dividend History.

▶ Synergy Pharma (SGYP): The NASDAQ-listed New York, NY-based Synergy Pharmaceuticals Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Companys product candidates include TRULANCE (plecanatide) and ....See Detailed Company Profile  and Dividend History.

▶ Synthetic Biologics (SYN): The AMEX-listed Michigan, MI-based Synthetic Biologics, Inc., incorporated on December 23, 2008, is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Companys ....See Detailed Company Profile  and Dividend History.

▶ Syros Pharma (SYRS): The NASDAQ-listed Massachusetts, MA-based Syros Pharmaceuticals, Inc., incorporated on November 9, 2011, is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in ....See Detailed Company Profile  and Dividend History.

▶ TapImmune (TPIV): The NASDAQ-listed Florida, FL-based TapImmune Inc., incorporated on October 22, 1991, is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The ....See Detailed Company Profile  and Dividend History.

▶ Taro Pharmaceutical Industries (TARO): The NYSE-listed Israel-based Taro Pharmaceutical Industries Ltd. (Taro), incorporated on June 3, 1959, is a science-based pharmaceutical company. The Company develops, manufactures and markets prescription (Rx) and over-the-counter (OTC) pharmaceutical products, primarily in ....See Detailed Company Profile  and Dividend History.

▶ Teligent (TLGT): The NASDAQ-listed New Jersey, NJ-based Teligent, Inc., incorporated on August 26, 1977, is a specialty generic pharmaceutical company. Under the Companys own label, it markets and sells generic injectable pharmaceutical products in the United States ....See Detailed Company Profile  and Dividend History.

▶ TESARO (TSRO): The NASDAQ-listed Massachusetts, MA-based TESARO, Inc., incorporated on March 26, 2010, is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. The Company is developing ....See Detailed Company Profile  and Dividend History.

▶ Tetraphase Pharma (TTPH): The NASDAQ-listed Massachusetts, MA-based Tetraphase Pharmaceuticals, Inc. (Tetraphase), incorporated on July 7, 2006, is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing ....See Detailed Company Profile  and Dividend History.

▶ Teva Pharmaceutical Industries (TEVA): The NYSE-listed Israel-based Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. ....See Detailed Company Profile  and Dividend History.

▶ TG Therapeutics (TGTX): The NASDAQ-listed New York, NY-based TG Therapeutics, Inc. (TG), incorporated on May 18, 1993, is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of ....See Detailed Company Profile  and Dividend History.

▶ The Medicines (MDCO): The NASDAQ-listed New Jersey, NJ-based The Medicines Company, incorporated on July 31, 1996, is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery ....See Detailed Company Profile  and Dividend History.

▶ TherapeuticsMD (TXMD): The AMEX-listed Florida, FL-based TherapeuticsMD, Inc., incorporated on July 20, 2010, is a womens healthcare company, which is engaged in creating and commercializing products for women. The Company is focused on pursuing the regulatory ....See Detailed Company Profile  and Dividend History.

▶ Theravance Biopharma (TBPH): The NASDAQ-listed Cayman Islands-based Theravance Biopharma, Inc. (Theravance Biopharma) is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery ....See Detailed Company Profile  and Dividend History.

▶ Threshold Pharma (THLD): The NASDAQ-listed California, CA-based Threshold Pharmaceuticals, Inc. (Threshold), incorporated on October 17, 2001, is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively ....See Detailed Company Profile  and Dividend History.

▶ TiGenix (TIG): The NASDAQ-listed Belgium-based Romeinse Straat 12....See Detailed Company Profile  and Dividend History.

▶ Tokai Pharma (TKAI): The NASDAQ-listed Massachusetts, MA-based Tokai Pharmaceuticals, Inc., incorporated on March 26, 2004, is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of prostate cancer and other hormonally ....See Detailed Company Profile  and Dividend History.

▶ Tonix Pharma Holding (TNXP): The NASDAQ-listed New York, NY-based Tonix Pharmaceuticals Holding Corp. (Tonix), incorporated on November 16, 2007, is a clinical-stage pharmaceutical company. The Companys drug development programs are directed toward disorders affecting the central nervous system (CNS), ....See Detailed Company Profile  and Dividend History.

▶ Trevena (TRVN): The NASDAQ-listed Pennsylvania, PA-based Trevena Inc., incorporated on November 9, 2007, is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator ....See Detailed Company Profile  and Dividend History.

▶ Trillium Therapeutics (TRIL): The NASDAQ-listed Canada-based Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ....See Detailed Company Profile  and Dividend History.

▶ Ultragenyx Pharmaceutical (RARE): The NASDAQ-listed California, CA-based Ultragenyx Pharmaceutical Inc., incorporated on June 13, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of ....See Detailed Company Profile  and Dividend History.

▶ uniQure (QURE): The NASDAQ-listed Netherlands-based uniQure N.V. (uniQure) is a gene therapy company. The Company is engaged in developing single treatments with curative results for patients suffering from genetic and other severe diseases. The Company ....See Detailed Company Profile  and Dividend History.

▶ United Therapeutics (UTHR): The NASDAQ-listed Maryland, MD-based United Therapeutics Corporation, incorporated on June 26, 1996, is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening ....See Detailed Company Profile  and Dividend History.

▶ Valeant Pharma International (VRX): The NYSE-listed Canada-based Valeant Pharmaceuticals International, Inc., incorporated on August 9, 2013, is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, ....See Detailed Company Profile  and Dividend History.

▶ Vanda Pharma (VNDA): The NASDAQ-listed Maryland, MD-based Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product ....See Detailed Company Profile  and Dividend History.

▶ Vascular Biogenics (VBLT): The NASDAQ-listed Israel-based Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Companys program ....See Detailed Company Profile  and Dividend History.

▶ Verastem (VSTM): The NASDAQ-listed Massachusetts, MA-based Verastem, Inc., incorporated on August 4, 2010, is a biopharmaceutical company. The Company is focused on discovering and developing drugs to improve outcomes for patients with cancer. The Company operates ....See Detailed Company Profile  and Dividend History.

▶ Versartis (VSAR): The NASDAQ-listed California, CA-based Versartis, Inc., incorporated on December 10, 2008, is an endocrine-focused biopharmaceutical company. The Company is engaged in developing a long-acting form of recombinant human growth hormone, somavaratan (VRS-317), for growth ....See Detailed Company Profile  and Dividend History.

▶ Vertex Pharma (VRTX): The NASDAQ-listed Cambridge, Massachusetts-based Vertex Pharmaceuticals Incorporated, incorporated on January 4, 1989, is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for ....See Detailed Company Profile  and Dividend History.

▶ Viking Therapeutics (VKTX): The NASDAQ-listed California, CA-based Viking Therapeutics, Inc., incorporated on October 24, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Companys clinical program, ....See Detailed Company Profile  and Dividend History.

▶ Viking Therapeutics (VKTXW): The NASDAQ-listed California, CA-based ....See Detailed Company Profile  and Dividend History.

▶ VistaGen Therapeutics (VTGN): The NASDAQ-listed California, CA-based VistaGen Therapeutics, Inc., incorporated on October 6, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving ....See Detailed Company Profile  and Dividend History.

▶ Vital Therapies (VTL): The NASDAQ-listed California, CA-based Vital Therapies, Inc., incorporated on January 13, 2004, is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its ....See Detailed Company Profile  and Dividend History.

▶ VIVUS (VVUS): The NASDAQ-listed California, CA-based VIVUS, Inc., incorporated on May 16, 1996, is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by ....See Detailed Company Profile  and Dividend History.

▶ vTv Therapeutics (VTVT): The NASDAQ-listed North Carolina, NC-based vTv Therapeutics Inc., incorporated on April 02, 2015, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. The ....See Detailed Company Profile  and Dividend History.

▶ WAVE Life Sciences (WVE): The NASDAQ-listed Singapore-based WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for ....See Detailed Company Profile  and Dividend History.

▶ XBiotech (XBIT): The NASDAQ-listed Texas, TX-based XBiotech Inc., incorporated on September 23, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different ....See Detailed Company Profile  and Dividend History.

▶ Xencor (XNCR): The NASDAQ-listed California, CA-based Xencor, Inc., incorporated on June 8, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. ....See Detailed Company Profile  and Dividend History.

▶ Xenetic Biosciences (XBIO): The NASDAQ-listed Maryland, MD-based Xenetic Biosciences, Inc., incorporated on August 9, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans ....See Detailed Company Profile  and Dividend History.

▶ Xenon Pharma (XENE): The NASDAQ-listed Canada-based Xenon Pharmaceuticals Inc. (Xenon), incorporated on May 17, 2000, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. ....See Detailed Company Profile  and Dividend History.

▶ XOMA (XOMA): The NASDAQ-listed California, CA-based XOMA Corporation, incorporated on December 31, 2011, is a development-stage biotechnology company with a portfolio of therapeutic antibodies. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. ....See Detailed Company Profile  and Dividend History.

▶ XTL BioPharma (XTLB): The NASDAQ-listed Israel-based XTL Biopharmaceuticals Ltd., incorporated on March 9, 1993, is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its ....See Detailed Company Profile  and Dividend History.

▶ Zafgen (ZFGN): The NASDAQ-listed Massachusetts, MA-based Zafgen, Inc., incorporated on November 22, 2005, is a biopharmaceutical company. The Company is focused on improving the health and well-being of patients affected by obesity and complex metabolic disorders. ....See Detailed Company Profile  and Dividend History.

▶ ZIOPHARM Oncology (ZIOP): The NASDAQ-listed New York, NY-based ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown anti....See Detailed Company Profile  and Dividend History.

▶ Zoetis (ZTS): The NYSE-listed New Jersey, NJ-based Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion ....See Detailed Company Profile  and Dividend History.

▶ Zogenix (ZGNX): The NASDAQ-listed California, CA-based Zogenix, Inc., incorporated on May 11, 2006, is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with ....See Detailed Company Profile  and Dividend History.

▶ Zosano Pharma (ZSAN): The NASDAQ-listed California, CA-based Zosano Pharma Corporation, incorporated on January 26, 2012, is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs ....See Detailed Company Profile  and Dividend History.

▶ Zynerba Pharma (ZYNE): The NASDAQ-listed Pennsylvania, PA-based Zynerba Pharmaceuticals, Inc., incorporated on January 31, 2007, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet ....See Detailed Company Profile  and Dividend History.

Dividend Stocks of Major Pharmaceuticals Sector

Among all the stocks of the Major Pharmaceuticals sector which are included in the above mentioned all-inclusive stock list, a few are known to be regular dividend paying stocks. The list of such frequent dividend paying stocks of the Major Pharmaceuticals can be explored as follows. It is based on the recent records of dividends announced/paid by the company since the date/month mentioned for each stock. Owing to the limited number of dividend records maintained by FKnol.com, it is possible that a particular company may have paid more or less dividends.

Frequent Dividend Payers of Major Pharmaceuticals Sector

▶ Eli Lilly (LLY) has paid 8 dividends since May 2017. See Dividend History  Company Profile

▶ Johnson and Johnson (JNJ) has paid 8 dividends since May 2017. See Dividend History  Company Profile

▶ Merck (MRK) has paid 8 dividends since June 2017. See Dividend History  Company Profile

▶ Pfizer (PFE) has paid 8 dividends since May 2017. See Dividend History  Company Profile

▶ Phibro Animal Health (PAHC) has paid 8 dividends since May 2017. See Dividend History  Company Profile

▶ Zoetis (ZTS) has paid 8 dividends since June 2017. See Dividend History  Company Profile

▶ Abbott Labs (ABT) has paid 7 dividends since July 2017. See Dividend History  Company Profile

▶ Allergan (AGN) has paid 7 dividends since May 2017. See Dividend History  Company Profile

▶ Bristol-Myers Squibb (BMY) has paid 7 dividends since July 2017. See Dividend History  Company Profile

▶ GlaxoSmithKline (GSK) has paid 7 dividends since May 2017. See Dividend History  Company Profile

▶ Perrigo (PRGO) has paid 7 dividends since May 2017. See Dividend History  Company Profile

▶ AbbVie (ABBV) has paid 6 dividends since October 2017. See Dividend History  Company Profile

▶ Astrazeneca (AZN) has paid 3 dividends since February 2018. See Dividend History  Company Profile

▶ Novartis AG (NVS) has paid 3 dividends since March 2018. See Dividend History  Company Profile

▶ Novo Nordisk (NVO) has paid 3 dividends since March 2018. See Dividend History  Company Profile

▶ Dr. Reddy's Laboratories (RDY) has paid 2 dividends since July 2017. See Dividend History  Company Profile

▶ Sanofi (SNY) has paid 2 dividends since May 2017. See Dividend History  Company Profile

▶ Teva Pharmaceutical Industries (TEVA) has paid 2 dividends since June 2017. See Dividend History  Company Profile

▶ Grifols (GRFS) has paid 1 dividend since November 2018. See Dividend History  Company Profile

▶ Merrimack Pharma (MACK) has paid 1 dividend since May 2017. See Dividend History  Company Profile

▶ Shire (SHPG) has paid 1 dividend since March 2018. See Dividend History  Company Profile

Stock List of Other Health Care Sub-sectors

▶ Stocks of sub-sector

▶ Stocks of Biotech sub-sector

▶ Stocks of Biotech Apparatus sub-sector

▶ Stocks of Biotech Diagnostics sub-sector

▶ Stocks of Biotech Products sub-sector

▶ Stocks of Biotech Research sub-sector

▶ Stocks of Drug Delivery sub-sector

▶ Stocks of Drug Development sub-sector

▶ Stocks of Drug Manufacturer sub-sector

▶ Stocks of Health Care sub-sector

▶ Stocks of Health Care Equipment and Services sub-sector

▶ Stocks of Hospital and Nursing Management sub-sector

▶ Stocks of Industrial Specialties sub-sector

▶ Stocks of Medical Dental Instruments sub-sector

▶ Stocks of Medical Electronics sub-sector

▶ Stocks of Medical Nursing Services sub-sector

▶ Stocks of Medical Products sub-sector

▶ Stocks of Medical Specialities sub-sector

▶ Stocks of Ophthalmic Goods sub-sector

▶ Stocks of Other Pharmaceuticals sub-sector

▶ Stocks of Precision Instruments sub-sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector


Search This Site